Cargando…
Interferon-gamma treatment kinetics among patients with active pulmonary tuberculosis
INTRODUCTION: Interferon-γ (IFN-γ) is essential for defence against Mycobacterium tuberculosis; however, levels in patients with active tuberculosis (TB) and changes during treatment have not been documented in our tuberculosis patients in Nigeria, hence this study has been carried out. OBJECTIVE: T...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3948958/ https://www.ncbi.nlm.nih.gov/pubmed/24665150 http://dx.doi.org/10.4103/0300-1652.126287 |
_version_ | 1782306861761953792 |
---|---|
author | Adewole, Olanisun Olufemi Ota, Martin O. Erhabor, Greg E. Owiafe, Patrick Oladimeji, Aliu Obaseki, Daniel |
author_facet | Adewole, Olanisun Olufemi Ota, Martin O. Erhabor, Greg E. Owiafe, Patrick Oladimeji, Aliu Obaseki, Daniel |
author_sort | Adewole, Olanisun Olufemi |
collection | PubMed |
description | INTRODUCTION: Interferon-γ (IFN-γ) is essential for defence against Mycobacterium tuberculosis; however, levels in patients with active tuberculosis (TB) and changes during treatment have not been documented in our tuberculosis patients in Nigeria, hence this study has been carried out. OBJECTIVE: To determine variations, treatment kinetics, and predictive value of IFN-γ levels during treatment of active tuberculosis. DESIGN: Patients with pulmonary tuberculosis were recruited and subsequently followed up for 3 months during treatment with anti-TB. Peripheral blood was collected for IFN-γ assays, C-reactive protein and others followed by a Mantoux test. IFN-γ levels produced by stimulation with TB antigens were determined by ELISA and repeated measurement of IFN-γ were done at 1 and 3 months of anti-TB therapy. Chi Associations and correlations between IFN-γ were determined. Regression analysis was done to determine association between serial IFN-γ and treatment outcome. RESULTS: We recruited 47 patients with active tuberculosis with a mean age of 34.8 ± 3.6 years and M:F ratio of 1.12:1. Six (11%) were HIV positive. The mean level of IFN-γ induced by TB antigens was 629 ± 114.1 pg/ml, higher for HIV-negative PTB patients compared with HIV-positive PTB patients, 609.78 ± 723.9 pg/ml and 87.88 ± 130.0 pg/ml, respectively, P-value = 0.000. The mean level of IFN-γ induced by TB antigen increased significantly from 629 ± 114.1 pg/ml to 1023.46 + 222.8 pg/ml, P-value = 0.03 and reduced to 272.3 ± 87.7 pg/ml by the third month on anti-TB drugs, P-value = 0.001. Negative correlation was observed between the mean of baseline and chest X-ray involvement, P = 0.03. There was no significant correlation between sputum smear grade with baseline and follow-up IFN-γ levels. Three-month IFN-γ level among cured patients were higher than those with treatment failure, regression analysis showed that it does not predict outcome. CONCLUSION: IFN-γ may be useful in early detection and monitoring response; however, large scale studies are needed. |
format | Online Article Text |
id | pubmed-3948958 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-39489582014-03-24 Interferon-gamma treatment kinetics among patients with active pulmonary tuberculosis Adewole, Olanisun Olufemi Ota, Martin O. Erhabor, Greg E. Owiafe, Patrick Oladimeji, Aliu Obaseki, Daniel Niger Med J Original Article INTRODUCTION: Interferon-γ (IFN-γ) is essential for defence against Mycobacterium tuberculosis; however, levels in patients with active tuberculosis (TB) and changes during treatment have not been documented in our tuberculosis patients in Nigeria, hence this study has been carried out. OBJECTIVE: To determine variations, treatment kinetics, and predictive value of IFN-γ levels during treatment of active tuberculosis. DESIGN: Patients with pulmonary tuberculosis were recruited and subsequently followed up for 3 months during treatment with anti-TB. Peripheral blood was collected for IFN-γ assays, C-reactive protein and others followed by a Mantoux test. IFN-γ levels produced by stimulation with TB antigens were determined by ELISA and repeated measurement of IFN-γ were done at 1 and 3 months of anti-TB therapy. Chi Associations and correlations between IFN-γ were determined. Regression analysis was done to determine association between serial IFN-γ and treatment outcome. RESULTS: We recruited 47 patients with active tuberculosis with a mean age of 34.8 ± 3.6 years and M:F ratio of 1.12:1. Six (11%) were HIV positive. The mean level of IFN-γ induced by TB antigens was 629 ± 114.1 pg/ml, higher for HIV-negative PTB patients compared with HIV-positive PTB patients, 609.78 ± 723.9 pg/ml and 87.88 ± 130.0 pg/ml, respectively, P-value = 0.000. The mean level of IFN-γ induced by TB antigen increased significantly from 629 ± 114.1 pg/ml to 1023.46 + 222.8 pg/ml, P-value = 0.03 and reduced to 272.3 ± 87.7 pg/ml by the third month on anti-TB drugs, P-value = 0.001. Negative correlation was observed between the mean of baseline and chest X-ray involvement, P = 0.03. There was no significant correlation between sputum smear grade with baseline and follow-up IFN-γ levels. Three-month IFN-γ level among cured patients were higher than those with treatment failure, regression analysis showed that it does not predict outcome. CONCLUSION: IFN-γ may be useful in early detection and monitoring response; however, large scale studies are needed. Medknow Publications & Media Pvt Ltd 2013 /pmc/articles/PMC3948958/ /pubmed/24665150 http://dx.doi.org/10.4103/0300-1652.126287 Text en Copyright: © Nigerian Medical Journal http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Adewole, Olanisun Olufemi Ota, Martin O. Erhabor, Greg E. Owiafe, Patrick Oladimeji, Aliu Obaseki, Daniel Interferon-gamma treatment kinetics among patients with active pulmonary tuberculosis |
title | Interferon-gamma treatment kinetics among patients with active pulmonary tuberculosis |
title_full | Interferon-gamma treatment kinetics among patients with active pulmonary tuberculosis |
title_fullStr | Interferon-gamma treatment kinetics among patients with active pulmonary tuberculosis |
title_full_unstemmed | Interferon-gamma treatment kinetics among patients with active pulmonary tuberculosis |
title_short | Interferon-gamma treatment kinetics among patients with active pulmonary tuberculosis |
title_sort | interferon-gamma treatment kinetics among patients with active pulmonary tuberculosis |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3948958/ https://www.ncbi.nlm.nih.gov/pubmed/24665150 http://dx.doi.org/10.4103/0300-1652.126287 |
work_keys_str_mv | AT adewoleolanisunolufemi interferongammatreatmentkineticsamongpatientswithactivepulmonarytuberculosis AT otamartino interferongammatreatmentkineticsamongpatientswithactivepulmonarytuberculosis AT erhaborgrege interferongammatreatmentkineticsamongpatientswithactivepulmonarytuberculosis AT owiafepatrick interferongammatreatmentkineticsamongpatientswithactivepulmonarytuberculosis AT oladimejialiu interferongammatreatmentkineticsamongpatientswithactivepulmonarytuberculosis AT obasekidaniel interferongammatreatmentkineticsamongpatientswithactivepulmonarytuberculosis |